Blockchain Registration Transaction Record

Onco-Innovations Targets Cancer with DNA Repair Inhibitors and AI

Onco-Innovations develops PNKP inhibitors and AI-driven precision oncology. Learn how this clinical-stage company targets DNA repair pathways to fight cancer.

This news matters because Onco-Innovations is advancing a novel class of cancer therapies that target DNA repair mechanisms, which could revolutionize treatment for solid tumors. For patients, this means potential new options when current therapies fail due to resistance. For investors, the company's dual approach combining drug development with AI could accelerate discovery and improve success rates, making it a compelling opportunity in the oncology space.